Case Evidence
Every figure below is reconciled against the hospital's Hospital Information System. Names withheld per Master Services Agreement; each case is verifiable under NDA on request.
STUDY · RDV-0417
342-bed cardiac SSH · Tier-1 metro
IP Admissions
412
vs. baseline 128
ROAS (IP revenue)
11.7×
Ad spend → billed IP
CAC / Admission
₹18,420
from ₹64,800
OT Utilization
87%
from 27%
“For the first time we could reconcile every admission to a campaign in the HIS. That is the number the board asked for.”
STUDY · RDV-0521
220-bed oncology block · South India
Robotic Cases
184
vs. baseline 41
ROAS (IP revenue)
9.2×
Da Vinci case-mix
Second-Opinion Fill
72%
of tumour-board slots
Intl. Patient Share
18%
GCC inbound
“They understood the difference between a screening lead and a surgical candidate. That changed our call-center scripts overnight.”
STUDY · RDV-0619
180-bed multi-specialty · Tier-2 city
Joint Replacements
318
vs. baseline 96
ROAS (IP revenue)
14.1×
Bundle pricing model
Bed Occupancy
93%
Ortho ward, 6-mo avg.
Lead → Admit SLA
< 48 hrs
Median
“They moved us from broadcast advertising to a referral-and-consult engine. Occupancy stopped being a monthly worry.”
Figures are engagement-verified and reconciled against each hospital's HIS. Individual results vary by specialty, catchment and clinical capacity. No outcome guarantees are implied; communications governed by NMC advertising guidelines.
